Position in MYGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$32,746,850
+$25,330,850 QoQ
Shares Held
5,735,000
+248.0% QoQ
Ownership
6.00%
of shares outstanding
% of Portfolio
0.77%
of 13F equity value
Holder Rank
#3
of 197 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Vestal Point Capital, LP holds $32,746,850 across 1 Diagnostics & Research name. MYGN ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MYGN |
Myriad Genetics Inc
This page
|
5,735,000 | $32,746,850 |
All Filings in MYGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,746,850 | 5,735,000 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $32,746,850 | 5,735,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,416,000 | 1,648,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,521,450 | 1,223,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,338,000 | 600,000 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||